Gumbohatch Each 0.05 mL (In-Ovo) or 0.2 mL (SC) (dose) contains: Live attenuated infectious bursal disease virus (IBD) (1052 strain)-10^1.48 - 10^2.80* Infectious Bursal Disease (IBD) Virus-specific antibody-2.7x10^6 IgY** *PU: Polacy Units **VNU: Virus Neutralization Units Lyophilized Powder for Injection (In-Ovo/SC)

Valsts: Filipīnas

Valoda: angļu

Klimata pārmaiņas: FDA (Food And Drug Administration)

Aktīvā sastāvdaļa:

Live Attenuated Infectious Bursal Disease (IBD) Virus , Infectious Bursal Disease (IBD) Virus-Specific Antibody Complexed Vaccine (Vet.)

Pieejams no:

Hipra Philippines, Inc.; Distributor: Hipra Philippines, Inc.

SNN (starptautisko nepatentēto nosaukumu):

Live Attenuated Infectious Bursal Disease (IBD) Virus + Infectious Bursal Disease (IBD) Virus-Specific Antibody Complexed Vaccine (Vet.)

Deva:

Each 0.05 mL (In-Ovo) or 0.2 mL (SC) (dose) contains: Live attenuated infectious bursal disease virus (IBD) (1052 strain)-10^1.48 - 10^2.80* Infectious Bursal Disease (IBD) Virus-specific antibody-2.7x10^6 IgY** *PU: Polacy Units **VNU: Virus Neutralization Units

Zāļu forma:

Lyophilized Powder for Injection (In-Ovo/SC)

Vienības iepakojumā:

Type I Glass Vial containing the Lyophilized Powder with Rubber Stopper and Aluminum Cap x 1,000 doses, 2,000 doses, 2,500 doses, 4,000 doses, 5,000 doses (Box of 10's); PP bags containing the Solvent x 200 ml, 400 mL, 500 mL, 800 mL and 1,000 mL (Box of 10's)

Ražojis:

Laboratorios Hipra, S.A., Spain

Autorizācija datums:

2021-10-22